D
CannaPharmaRX, Inc.
CPMD
$0.0055
$0.000.00%
D
Sell
11/27/2024Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D+ from D on 11/27/2024 due to an increase in the efficiency index, total return index and volatility index. Total capital increased 25.65% from -$2.94M to -$2.19M.
CannaPharmaRX, Inc. (CPMD) was upgraded to D+ from D on 11/27/2024 due to an increase in the efficiency index, total return index and volatility index. Total capital increased 25.65% from -$2.94M to -$2.19M.
D
Sell
10/3/2024Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D from D+ on 10/3/2024 due to a decline in the volatility index and total return index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D from D+ on 10/3/2024 due to a decline in the volatility index and total return index.
D
Sell
9/18/2024Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D+ from D on 9/18/2024 due to an increase in the volatility index and total return index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D+ from D on 9/18/2024 due to an increase in the volatility index and total return index.
D
Sell
8/19/2024Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 8/19/2024 due to a significant increase in the efficiency index, total return index and growth index. Net income increased 145.77% from -$11.72M to $5.36M, earnings per share increased from -$0.0334 to $0.0081, and total capital increased 71.01% from -$10.14M to -$2.94M.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 8/19/2024 due to a significant increase in the efficiency index, total return index and growth index. Net income increased 145.77% from -$11.72M to $5.36M, earnings per share increased from -$0.0334 to $0.0081, and total capital increased 71.01% from -$10.14M to -$2.94M.
D
Sell
10/16/2023Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D- from E on 10/16/2023 due to a large increase in the volatility index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D- from E on 10/16/2023 due to a large increase in the volatility index.
E
Sell
10/13/2023Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to E from E+ on 10/13/2023 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to E from E+ on 10/13/2023 due to a decline in the volatility index.
E
Sell
9/27/2023Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to E+ from E on 9/27/2023 due to a large increase in the solvency index, growth index and volatility index. EBIT increased 77.52% from -$3.2M to -$720.3, earnings per share increased from -$0.0144 to -$0.0048, and the quick ratio increased from 0 to 0.
CannaPharmaRX, Inc. (CPMD) was upgraded to E+ from E on 9/27/2023 due to a large increase in the solvency index, growth index and volatility index. EBIT increased 77.52% from -$3.2M to -$720.3, earnings per share increased from -$0.0144 to -$0.0048, and the quick ratio increased from 0 to 0.
E
Sell
9/19/2023Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to E from E+ on 9/19/2023 due to a major decline in the growth index, volatility index and total return index. EBIT declined 444.37% from -$588.5 to -$3.2M, earnings per share declined from -$0.0054 to -$0.0144, and operating cash flow declined 25.37% from -$338.6 to -$424.5.
CannaPharmaRX, Inc. (CPMD) was downgraded to E from E+ on 9/19/2023 due to a major decline in the growth index, volatility index and total return index. EBIT declined 444.37% from -$588.5 to -$3.2M, earnings per share declined from -$0.0054 to -$0.0144, and operating cash flow declined 25.37% from -$338.6 to -$424.5.
E
Sell
3/14/2023Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to E+ from D- on 03/14/2023.
CannaPharmaRX, Inc. (CPMD) was downgraded to E+ from D- on 03/14/2023.
D
Sell
3/3/2023Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 3/3/2023 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 3/3/2023 due to a decline in the volatility index.
D
Sell
2/14/2023Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from E+ on 2/14/2023 due to an increase in the volatility index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from E+ on 2/14/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to E+ from D- on 02/08/2023.
CannaPharmaRX, Inc. (CPMD) was downgraded to E+ from D- on 02/08/2023.
D
Sell
2/2/2023Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 2/2/2023 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 2/2/2023 due to a decline in the volatility index.
D
Sell
1/17/2023Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 1/17/2023 due to an increase in the volatility index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 1/17/2023 due to an increase in the volatility index.
D
Sell
12/30/2022Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 12/30/2022 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 12/30/2022 due to a decline in the volatility index.
D
Sell
12/15/2022Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 12/15/2022 due to an increase in the volatility index and total return index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 12/15/2022 due to an increase in the volatility index and total return index.
D
Sell
11/25/2022Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 11/25/2022 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 11/25/2022 due to a decline in the volatility index.
D
Sell
11/23/2022Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 11/23/2022 due to an increase in the volatility index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 11/23/2022 due to an increase in the volatility index.
D
Sell
11/3/2022Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 11/3/2022 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 11/3/2022 due to a decline in the volatility index.
D
Sell
10/19/2022Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 10/19/2022 due to an increase in the volatility index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 10/19/2022 due to an increase in the volatility index.
D
Sell
9/30/2022Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 9/30/2022 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 9/30/2022 due to a decline in the volatility index.
D
Sell
9/14/2022Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 9/14/2022 due to an increase in the volatility index and total return index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 9/14/2022 due to an increase in the volatility index and total return index.
D
Sell
8/25/2022Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 8/25/2022 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 8/25/2022 due to a decline in the volatility index.
D
Sell
8/23/2022Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 8/23/2022 due to an increase in the volatility index and total return index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 8/23/2022 due to an increase in the volatility index and total return index.
D
Sell
8/3/2022Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 8/3/2022 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 8/3/2022 due to a decline in the volatility index.
D
Sell
7/19/2022Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 7/19/2022 due to an increase in the volatility index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 7/19/2022 due to an increase in the volatility index.
D
Sell
5/24/2022Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D- from E+ on 5/24/2022 due to a major increase in the growth index. Earnings per share increased from -$0.0675 to -$0.0139.
CannaPharmaRX, Inc. (CPMD) was upgraded to D- from E+ on 5/24/2022 due to a major increase in the growth index. Earnings per share increased from -$0.0675 to -$0.0139.
E
Sell
4/18/2022Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to E+ from D- on 4/18/2022 due to a major decline in the growth index and volatility index. Earnings per share declined from -$0.0122 to -$0.0675.
CannaPharmaRX, Inc. (CPMD) was downgraded to E+ from D- on 4/18/2022 due to a major decline in the growth index and volatility index. Earnings per share declined from -$0.0122 to -$0.0675.
D
Sell
3/30/2022Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 3/30/2022 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 3/30/2022 due to a decline in the volatility index.
D
Sell
3/15/2022Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 3/15/2022 due to an increase in the volatility index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 3/15/2022 due to an increase in the volatility index.
D
Sell
2/16/2022Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 2/16/2022 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 2/16/2022 due to a decline in the volatility index.
D
Sell
1/31/2022Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 1/31/2022 due to an increase in the volatility index and total return index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 1/31/2022 due to an increase in the volatility index and total return index.
D
Sell
1/10/2022Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 1/10/2022 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 1/10/2022 due to a decline in the volatility index.
D
Sell
12/23/2021Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 12/23/2021 due to an increase in the volatility index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 12/23/2021 due to an increase in the volatility index.
D
Sell
12/3/2021Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 12/3/2021 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 12/3/2021 due to a decline in the volatility index.
D
Sell
11/17/2021Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 11/17/2021 due to an increase in the volatility index and total return index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 11/17/2021 due to an increase in the volatility index and total return index.
D
Sell
11/16/2021Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D- from E+ on 11/16/2021 due to a large increase in the growth index. Earnings per share increased from -$0.0291 to -$0.0122, and EBIT increased 29.44% from -$796.1 to -$561.7.
CannaPharmaRX, Inc. (CPMD) was upgraded to D- from E+ on 11/16/2021 due to a large increase in the growth index. Earnings per share increased from -$0.0291 to -$0.0122, and EBIT increased 29.44% from -$796.1 to -$561.7.
E
Sell
11/4/2021Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to E+ from D- on 11/4/2021 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to E+ from D- on 11/4/2021 due to a decline in the volatility index.
D
Sell
10/13/2021Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D- from E+ on 10/13/2021 due to an increase in the volatility index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D- from E+ on 10/13/2021 due to an increase in the volatility index.
E
Sell
9/24/2021Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to E+ from D- on 9/24/2021 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to E+ from D- on 9/24/2021 due to a decline in the volatility index.
D
Sell
9/8/2021Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D- from E+ on 9/8/2021 due to an increase in the volatility index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D- from E+ on 9/8/2021 due to an increase in the volatility index.
E
Sell
8/20/2021Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to E+ from D- on 8/20/2021 due to a large decline in the growth index and volatility index. Earnings per share declined from $0.0249 to -$0.0291, and EBIT declined 10.37% from -$721.3 to -$796.1.
CannaPharmaRX, Inc. (CPMD) was downgraded to E+ from D- on 8/20/2021 due to a large decline in the growth index and volatility index. Earnings per share declined from $0.0249 to -$0.0291, and EBIT declined 10.37% from -$721.3 to -$796.1.
D
Sell
8/13/2021Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 8/13/2021 due to a decline in the volatility index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 8/13/2021 due to a decline in the volatility index.
D
Sell
7/26/2021Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 7/26/2021 due to an increase in the volatility index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 7/26/2021 due to an increase in the volatility index.
D
Sell
7/9/2021Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 7/9/2021 due to a decline in the volatility index and total return index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 7/9/2021 due to a decline in the volatility index and total return index.
D
Sell
5/18/2021Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 5/18/2021 due to a large increase in the growth index and valuation index. Earnings per share increased from -$0.3295 to $0.02, and EBIT increased 62.03% from -$1.9M to -$721.3.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 5/18/2021 due to a large increase in the growth index and valuation index. Earnings per share increased from -$0.3295 to $0.02, and EBIT increased 62.03% from -$1.9M to -$721.3.
D
Sell
1/8/2021Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 1/8/2021 due to a decline in the total return index, volatility index and valuation index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 1/8/2021 due to a decline in the total return index, volatility index and valuation index.
D
Sell
11/16/2020Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 11/16/2020 due to a noticeable increase in the growth index and volatility index. Operating cash flow increased 48.33% from -$307.7 to -$159.
CannaPharmaRX, Inc. (CPMD) was upgraded to D from D- on 11/16/2020 due to a noticeable increase in the growth index and volatility index. Operating cash flow increased 48.33% from -$307.7 to -$159.
D
Sell
10/8/2020Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 10/8/2020 due to a significant decline in the total return index, efficiency index and solvency index. The quick ratio declined from 0.02 to 0.
CannaPharmaRX, Inc. (CPMD) was downgraded to D- from D on 10/8/2020 due to a significant decline in the total return index, efficiency index and solvency index. The quick ratio declined from 0.02 to 0.
D
Sell
10/24/2019Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D from D+ on 10/24/2019 due to a noticeable decline in the efficiency index, total return index and growth index. Operating cash flow declined 75.58% from -$176.5 to -$309.9, and total capital declined 1.31% from $19.62M to $19.36M.
CannaPharmaRX, Inc. (CPMD) was downgraded to D from D+ on 10/24/2019 due to a noticeable decline in the efficiency index, total return index and growth index. Operating cash flow declined 75.58% from -$176.5 to -$309.9, and total capital declined 1.31% from $19.62M to $19.36M.
D
Sell
8/14/2019Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D+ from D on 8/14/2019 due to a significant increase in the total return index and volatility index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D+ from D on 8/14/2019 due to a significant increase in the total return index and volatility index.
D
Sell
7/30/2019Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D from D+ on 7/30/2019 due to a substantial decline in the total return index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D from D+ on 7/30/2019 due to a substantial decline in the total return index.
D
Sell
7/9/2019Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D+ from D on 7/9/2019 due to a substantial increase in the total return index and volatility index.
CannaPharmaRX, Inc. (CPMD) was upgraded to D+ from D on 7/9/2019 due to a substantial increase in the total return index and volatility index.
D
Sell
6/12/2019Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D from D+ on 6/12/2019 due to a decline in the total return index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D from D+ on 6/12/2019 due to a decline in the total return index.
D
Sell
5/28/2019Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to D+ from D on 5/28/2019 due to a noticeable increase in the total return index, growth index and solvency index. Operating cash flow increased 75.98% from -$734.9 to -$176.5, earnings per share increased from -$0.1073 to -$0.0486, and the quick ratio increased from 0.08 to 0.11.
CannaPharmaRX, Inc. (CPMD) was upgraded to D+ from D on 5/28/2019 due to a noticeable increase in the total return index, growth index and solvency index. Operating cash flow increased 75.98% from -$734.9 to -$176.5, earnings per share increased from -$0.1073 to -$0.0486, and the quick ratio increased from 0.08 to 0.11.
D
Sell
4/8/2019Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D from D+ on 4/8/2019 due to a significant decline in the efficiency index and growth index. Operating cash flow declined 336.14% from -$168.5 to -$734.9, net income declined 76.17% from -$1.09M to -$1.93M, and earnings per share declined from -$0.061 to -$0.1073.
CannaPharmaRX, Inc. (CPMD) was downgraded to D from D+ on 4/8/2019 due to a significant decline in the efficiency index and growth index. Operating cash flow declined 336.14% from -$168.5 to -$734.9, net income declined 76.17% from -$1.09M to -$1.93M, and earnings per share declined from -$0.061 to -$0.1073.
D
Sell
9/17/2018Downgrade
CannaPharmaRX, Inc. (CPMD) was downgraded to D+ from C- on 9/17/2018 due to a significant decline in the volatility index, total return index and solvency index.
CannaPharmaRX, Inc. (CPMD) was downgraded to D+ from C- on 9/17/2018 due to a significant decline in the volatility index, total return index and solvency index.
C
Hold
5/29/2015Upgraded
CannaPharmaRX, Inc. (CPMD) was upgraded to C- from D+ on 5/29/2015 due to a noticeable increase in the total return index, efficiency index and valuation index. Total capital increased 91.39% from -$288.2 to -$551.6.
CannaPharmaRX, Inc. (CPMD) was upgraded to C- from D+ on 5/29/2015 due to a noticeable increase in the total return index, efficiency index and valuation index. Total capital increased 91.39% from -$288.2 to -$551.6.
D
Sell
9/10/2014Downgrade
Golden Dragon Holding Co. (GDHC) was downgraded to D+ from C- on 9/10/2014 due to a major decline in the efficiency index, valuation index and growth index. Total capital declined 2,492.87% from -$82.7 to $1.98M.
Golden Dragon Holding Co. (GDHC) was downgraded to D+ from C- on 9/10/2014 due to a major decline in the efficiency index, valuation index and growth index. Total capital declined 2,492.87% from -$82.7 to $1.98M.
C
Hold
5/20/2014Downgrade
Golden Dragon Holding Co. (GDHC) was downgraded to C- from C on 5/20/2014 due to a major decline in the growth index and volatility index.
Golden Dragon Holding Co. (GDHC) was downgraded to C- from C on 5/20/2014 due to a major decline in the growth index and volatility index.
OTC PK
04/09/2025 9:32AM Eastern
Quotes delayed
